Anticoagulant effects of repeated subcutaneous injections of high doses of unfractionated heparin in healthy dogs
Authors:
- Christina SchüttertCSChristina Schüttert
- Susanne I. GrebeSGSusanne I. Grebe
- 1 December 2001
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 62 (12) , 1887-1891
Abstract
Objective—To evaluate SC administration of unfractionated heparin (UFH) in accordance with a dosing regimen for high-dose treatment in dogs. Animals—10 healthy adult Beagles. Procedures—Two groups of dogs (5 dogs/group) were given 6 injections of heparin (500 units of UFH/kg of body weight, SC) at intervals of 8 (experiment 1) and 12 (experiment 2) hours. Blood samples were collected before and 4 hours after heparin injections to determine amidolytic heparin activity, activated partial thromboplastin time (APTT), thrombin time, antithrombin activity, platelet count, and Hct. Results—For experiments 1 and 2, mean ± SD heparin activities before (experiment 1, 1.32 ± 0.20 U/ml; experiment 2, 0.69 ± 0.174 U/ml) and 4 hours after the last heparin injection (experiment 1, 1.71 ± 0.30 U/ml; experiment 2, 1.10 ± 0.30 U/ml) were higher than values calculated for the regimen used in experiment 1. Results of the investigated thrombin time test system with low thrombin activity were frequently beyond the measurement range, even with UFH activities ≥ 0.6 U/ml. Moreover, a severe decrease of antithrombin activity became evident during both experiments (eg, in experiment 2 from 95.6 ± 4.8 to 59.2 ± 6.6%). In each treatment group, 2 dogs developed hematomas. Conclusions and Clinical Relevance—Calculations of the course of heparin activity after a single injection do not result in a reliable dosing regimen for highdose heparin treatment in dogs. High-dose treatment must be monitored for each dog. Thrombin time measured with low thrombin activity is unsuitable for this purpose. (Am J Vet Res 2001;62:1887–1891)Keywords
This publication has 10 references indexed in Scilit:
- The monitoring of heparin administration by screening tests in experimental dogsResearch in Veterinary Science, 2001
- Heparin and Low-Molecular-Weight HeparinChest, 1998
- Differential Effects of Low Molecular Weight Heparin and Unfractionated Heparin on Circulating Levels of Antithrombin and Tissue Factor Pathway Inhibitor (TFPI): A Possible Mechanism for Difference in Therapeutic EfficacyThrombosis Research, 1998
- Heparin-induced Thrombocytopenia: Towards ConsensusThrombosis and Haemostasis, 1998
- Comparison of the effects of low-molecular-weight and unfractioned heparin in horsesAmerican Journal of Veterinary Research, 1995
- A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivoBlood Coagulation & Fibrinolysis, 1993
- Disseminated Intravascular CoagulationVeterinary Clinics of North America: Small Animal Practice, 1988
- Kinetics of intravenously administered heparin in normal humansBlood, 1982
- Heparin kinetics determined by three assay methodsClinical Pharmacology & Therapeutics, 1982
- Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin IIIThrombosis Research, 1977